<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>College News</title><link>http://medicine.osu.edu</link><description>description of blog</description><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/colmed" /><feedburner:info uri="colmed" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item><title>International Health Group Travels to Ghana</title><link>http://feedproxy.google.com/~r/colmed/~3/y_8RsfgHhQM/international-health-group-travels-to-ghana.aspx</link><description>&lt;div class="ExternalClass1C83E1A788E74FDDBFE5458D6E217E21"&gt;&lt;p&gt;​The International Health Interest Group, led by Dr. Howard Werman recently set out for Ghana to provide care to a variety of patients in villages throughout Ghana. Dr. Werman started at The Ohio State University College of Medicine in 1981 as an Emergency Medicine Resident. He joined the faculty in 1984 and is currently a Professor in the Department of Emergency Medicine.  He has traveled extensively to such places as Haiti, Honduras, and Qatar.&lt;br /&gt;&lt;br /&gt;The rewarding experience was captured in a series of photos that can be viewed, &lt;a href="https://www.facebook.com/media/set/?set=a.605804792776863.1073741828.259400437417302&amp;amp;type=1" target="_blank"&gt;here​&lt;/a&gt;.&lt;br /&gt;&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/y_8RsfgHhQM" height="1" width="1"/&gt;</description><pubDate>Mon, 20 May 2013 18:28:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/20/international-health-group-travels-to-ghana.aspx</feedburner:origLink></item><item><title>Randy Nelson, PhD, Named Distinguished University Professor </title><link>http://feedproxy.google.com/~r/colmed/~3/wwRVKPnOxFo/randy-nelson-phd-named-distinguished-university-professor.aspx</link><description>&lt;div class="ExternalClass1B446AEF00EF4D248C40195CE7281A0C"&gt;&lt;p&gt;​Please join us in congratulating Randy Nelson, PhD, professor and chair of the Department of Neuroscience, for his selection as a Distinguished University Professor. The Distinguished Professor award is a prestigious honor given permanently to no more than three exceptional faculty members per year. This title recognizes accomplishments in research, scholarly or creative work, teaching and service that are both distinguished and distinctive. &lt;/p&gt;
&lt;p&gt;Dr. Nelson, who holds the Dr. John D. and E. Olive Brumbaugh Chair in Brain Research and Teaching, is an internationally recognized leader in the field of behavioral neuroendocrinology, garnering significant recognition from the scientific community. He received all of his academic degrees from the University of California at Berkeley, including a PhD in Psychology and a PhD in Endocrinology. He completed a postdoctoral fellowship at the University of Texas. Dr. Nelson served on the faculty at Johns Hopkins University for 15 years before joining The Ohio State University in 2000 as professor of Social and Behavioral Sciences and professor of Psychology and Neuroscience. He has been the chair of the OSU Department of Neuroscience since 2009. &lt;/p&gt;
&lt;p&gt;Dr. Nelson has published more than 350 scientific articles and several books describing studies in biological rhythms, behavioral neuroendocrinology, stress and immune function. He has been elected to Fellow status in several scientific associations, including the American Association for the Advancement of Science. Dr. Nelson has been a member of many federal grant panels. He currently serves on the editorial boards of five scientific journals and is the associate editor for Hormones and Behavior, the journal of the Society for Behavioral Neuroendocrinology. &lt;/p&gt;
&lt;p&gt;At Ohio State, he has received the Distinguished Scholar Award, the University Distinguished Lecturer Award and the OSU Alumni Award for Distinguished Teaching. He was appointed Distinguished Professor of the College of Medicine in 2012. &lt;/p&gt;
&lt;p&gt;Congratulations to Dr. Nelson for receiving our University’s most prestigious award!​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/wwRVKPnOxFo" height="1" width="1"/&gt;</description><pubDate>Thu, 16 May 2013 17:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/neuroscience/news/archive/2013/05/16/randy-nelson-phd-named-distinguished-university-professor.aspx</feedburner:origLink></item><item><title>Randy Nelson, PhD, Named Distinguished University Professor</title><link>http://feedproxy.google.com/~r/colmed/~3/gdZcBGFeukA/randy-nelson-phd-named-distinguished-university-professor.aspx</link><description>&lt;div class="ExternalClassEACD5E5E1FAA494A9E698B29F4C70061"&gt;&lt;p&gt;​Please join us in congratulating Randy Nelson, PhD, professor and chair of the Department of Neuroscience, for his selection as a Distinguished University Professor. The Distinguished Professor award is a prestigious honor given permanently to no more than three exceptional faculty members per year. This title recognizes accomplishments in research, scholarly or creative work, teaching and service that are both distinguished and distinctive. &lt;/p&gt;
&lt;p&gt;Dr. Nelson, who holds the Dr. John D. and E. Olive Brumbaugh Chair in Brain Research and Teaching, is an internationally recognized leader in the field of behavioral neuroendocrinology, garnering significant recognition from the scientific community. He received all of his academic degrees from the University of California at Berkeley, including a PhD in Psychology and a PhD in Endocrinology. He completed a postdoctoral fellowship at the University of Texas. Dr. Nelson served on the faculty at Johns Hopkins University for 15 years before joining The Ohio State University in 2000 as professor of Social and Behavioral Sciences and professor of Psychology and Neuroscience. He has been the chair of the OSU Department of Neuroscience since 2009. &lt;/p&gt;
&lt;p&gt;Dr. Nelson has published more than 350 scientific articles and several books describing studies in biological rhythms, behavioral neuroendocrinology, stress and immune function. He has been elected to Fellow status in several scientific associations, including the American Association for the Advancement of Science. Dr. Nelson has been a member of many federal grant panels. He currently serves on the editorial boards of five scientific journals and is the associate editor for Hormones and Behavior, the journal of the Society for Behavioral Neuroendocrinology. &lt;/p&gt;
&lt;p&gt;At Ohio State, he has received the Distinguished Scholar Award, the University Distinguished Lecturer Award and the OSU Alumni Award for Distinguished Teaching. He was appointed Distinguished Professor of the College of Medicine in 2012. &lt;/p&gt;
&lt;p&gt;Congratulations to Dr. Nelson for receiving our University’s most prestigious award!​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/gdZcBGFeukA" height="1" width="1"/&gt;</description><pubDate>Thu, 16 May 2013 14:59:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/16/randy-nelson-phd-named-distinguished-university-professor.aspx</feedburner:origLink></item><item><title>AUA 2013: Early steps taken in using stem cells for infertility</title><link>http://feedproxy.google.com/~r/colmed/~3/xYHxeOQHkpY/aua-2013-early-steps-taken-in-using-stem-cells-for-infertility.aspx</link><description>&lt;div class="ExternalClass6FE1C712EF7E4CCAB3DCB6EA6E91FF20"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://urologytimes.modernmedicine.com/urology-times/news/aua-2013-early-steps-taken-using-stem-cells-infertility&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAIOAhAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNH3fgPiYSmS8GDP6MuPw8Obv5qZnw"&gt;&lt;span style="color:#1111cc"&gt;AUA 2013: Early steps taken in using stem cells for infertility&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;ModernMedicine&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;&lt;b&gt;...&lt;/b&gt; in whom sterility cannot be prevented and who have no means available to preserve fertility, said John D. Jackson, PhD, of the Wake Forest University School of Medicine and the Wake Forest Institute for &lt;b&gt;Regenerative Medicine&lt;/b&gt;, Winston-Salem, NC.&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/xYHxeOQHkpY" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:38:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/aua-2013-early-steps-taken-in-using-stem-cells-for-infertility.aspx</feedburner:origLink></item><item><title>An accelerator for America's future</title><link>http://feedproxy.google.com/~r/colmed/~3/9oNl8IkQVOQ/an-accelerator-for-americas-future.aspx</link><description>&lt;div class="ExternalClassA76E6534C25B46999DE67278D0E32763"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.tidewaternews.com/2013/05/11/an-accelerator-for-americas-future/&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAHOAdAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNGx11jdWrFP_eS5s0JwK5Tl79KiXA"&gt;&lt;span style="color:#1111cc"&gt;An accelerator for America's future&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Tidewater News&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Medical research has been called an accelerator for America's future and its successes are awe-inspiring: &lt;b&gt;Regenerative medicine&lt;/b&gt; research has given people a second chance at life. Stem cells were taken from a child's own bone marrow to create and &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/9oNl8IkQVOQ" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:38:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/an-accelerator-for-americas-future.aspx</feedburner:origLink></item><item><title>Stem Cell Research Centre for animals</title><link>http://feedproxy.google.com/~r/colmed/~3/bwq696mNkzs/stem-cell-research-centre-for-animals.aspx</link><description>&lt;div class="ExternalClassD932FAB5CF30443FAC266F73E6C6754D"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.thehindu.com/news/national/tamil-nadu/stem-cell-research-centre-for-animals/article4689915.ece&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAGOAZAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNEZLDFEvgogXVt20E381wZDXHp5Rw"&gt;&lt;span style="color:#1111cc"&gt;Stem Cell Research Centre for animals&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;The Hindu&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;If it proves successful, &lt;b&gt;regenerative medicine&lt;/b&gt; will provide alternative therapy even for organ transplantations. The principle could be translated to human medicines also, said a senior Professor in the university. Research activities in the new centre &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/bwq696mNkzs" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/stem-cell-research-centre-for-animals.aspx</feedburner:origLink></item><item><title>BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of ...</title><link>http://feedproxy.google.com/~r/colmed/~3/hXQ7kjv8SLo/biolife-solutions-announces-record-revenue-of-2-2-million-in-first-quarter-of-.aspx</link><description>&lt;div class="ExternalClass33FC6EC6EEAC4060B0438D3DE26F58A7"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://money.msn.com/business-news/article.aspx?feed%3DPR%26date%3D20130514%26id%3D16474168&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAFOAVAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNGElEI8Op_h4hWStX3DldtwpUQynw"&gt;&lt;span style="color:#1111cc"&gt;BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;MSN Money&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;The &lt;b&gt;regenerative medicine&lt;/b&gt; market is expected to grow to more than $35 billion by 2019, according to TriMark Publications' newly published &amp;quot;&lt;b&gt;Regenerative Medicine&lt;/b&gt; Markets&amp;quot; report. BioLife's addressable portion of the market is the demand for reagents &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/hXQ7kjv8SLo" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/biolife-solutions-announces-record-revenue-of-2-2-million-in-first-quarter-of-.aspx</feedburner:origLink></item><item><title>Disease-in-a-dish models show promise for treating ataxia telangiectasia</title><link>http://feedproxy.google.com/~r/colmed/~3/02awokqI1Fg/disease-in-a-dish-models-show-promise-for-treating-ataxia-telangiectasia.aspx</link><description>&lt;div class="ExternalClass67061272F18D4155AD32BF655E4DB16C"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.news-medical.net/news/20130513/Disease-in-a-dish-models-show-promise-for-treating-ataxia-telangiectasia.aspx&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAEOARAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNEHVxK2AvxXu6MMfeiG4jtorEGlEg"&gt;&lt;span style="color:#1111cc"&gt;Disease-in-a-dish models show promise for treating ataxia telangiectasia&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;News-Medical.net&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Led by Dr. Peiyee Lee and Dr. Richard Gatti, researchers at the Eli and Edythe Broad Center of &lt;b&gt;Regenerative Medicine&lt;/b&gt; and Stem Cell Research at UCLA have used induced pluripotent stem (iPS) cells to advance disease-in-a-dish modeling of a rare genetic &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/02awokqI1Fg" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/disease-in-a-dish-models-show-promise-for-treating-ataxia-telangiectasia.aspx</feedburner:origLink></item><item><title>Stem cell researchers move toward treatment for rare genetic nerve disease</title><link>http://feedproxy.google.com/~r/colmed/~3/--mSukgFUp8/stem-cell-researchers-move-toward-treatment-for-rare-genetic-nerve-disease.aspx</link><description>&lt;div class="ExternalClass4AC80CA455074177AEB9337EC9380FD9"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://medicalxpress.com/news/2013-05-stem-cell-treatment-rare-genetic.html&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATADOANAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNFDGGK7XH7HBK8bfU_1q62K-WnXSA"&gt;&lt;span style="color:#1111cc"&gt;Stem cell researchers move toward treatment for rare genetic nerve disease&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Medical Xpress&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;(Medical Xpress)—UCLA researchers at the Eli and Edythe Broad Center of &lt;b&gt;Regenerative Medicine&lt;/b&gt; and Stem Cell Research have used induced pluripotent stem cells (iPSC) to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/--mSukgFUp8" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/stem-cell-researchers-move-toward-treatment-for-rare-genetic-nerve-disease.aspx</feedburner:origLink></item><item><title>Neuromics and Vitro Biopharma Expand Collaboration to Target Drug Discovery ...</title><link>http://feedproxy.google.com/~r/colmed/~3/myWTOniK0A4/neuromics-and-vitro-biopharma-expand-collaboration-to-target-drug-discovery-.aspx</link><description>&lt;div class="ExternalClassE988AF55A571407291CE65DB332079CA"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.baystreet.ca/viewarticle.aspx?id%3D404150&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATACOAJAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNGkc04GaFC4oh0kAP1Z0v_B0FcWsQ"&gt;&lt;span style="color:#1111cc"&gt;Neuromics and Vitro Biopharma Expand Collaboration to Target Drug Discovery &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Baystreet.ca&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Golden, Colorado - Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced expansion of its distribution agreement with Neuromics to include targeted sales to select markets in drug discovery &amp;amp; &lt;b&gt;regenerative medicine&lt;/b&gt;. Early stages of drug &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/myWTOniK0A4" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/neuromics-and-vitro-biopharma-expand-collaboration-to-target-drug-discovery-.aspx</feedburner:origLink></item><item><title>Alligator stem cell study gives clues to tooth regeneration</title><link>http://feedproxy.google.com/~r/colmed/~3/aU0tM6TaUFs/alligator-stem-cell-study-gives-clues-to-tooth-regeneration.aspx</link><description>&lt;div class="ExternalClass275CE9CAB1DC4AA290CB79D1DB313661"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.healthcanal.com/medical-breakthroughs/38576-alligator-stem-cell-study-gives-clues-to-tooth-regeneration.html&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATABOAFAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNGybcKWd1I5lvDrPZxCTju6r2zIVQ"&gt;&lt;span style="color:#1111cc"&gt;Alligator stem cell study gives clues to tooth &lt;b&gt;regeneration&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;HealthCanal.com&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;By Allison Trinidad - Alligators may help scientists learn how to stimulate tooth &lt;b&gt;regeneration&lt;/b&gt; in people, according to new research led by the Keck School of &lt;b&gt;Medicine&lt;/b&gt; of USC. For the first time, a global team of researchers led by USC Professor Cheng &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/aU0tM6TaUFs" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/alligator-stem-cell-study-gives-clues-to-tooth-regeneration.aspx</feedburner:origLink></item><item><title>The dawn of regenerative medicine</title><link>http://feedproxy.google.com/~r/colmed/~3/ZQBRu3by41Q/the-dawn-of-regenerative-medicine.aspx</link><description>&lt;div class="ExternalClass89072CF6D14C429C90F2AEF6B80052C3"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.moneyweek.com/investment-advice/share-tips/the-dawn-of-regenerative-medicine-63808&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAAOABAj5rJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=Hc9S-eU8diE&amp;amp;usg=AFQjCNEtJyYUqVbk0XjpbXhf3Eu5ih2gog"&gt;&lt;span style="color:#1111cc"&gt;The dawn of &lt;b&gt;regenerative medicine&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;MoneyWeek&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;&lt;b&gt;Regenerative medicine&lt;/b&gt; will be able to help cure heart disease by successfully growing heart valves from human cells. This means heart valves will be repaired without the need to perform surgery. Researchers are also looking into helping stroke patients &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/ZQBRu3by41Q" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/the-dawn-of-regenerative-medicine.aspx</feedburner:origLink></item><item><title>Cell Medica begins treatment of paediatric patient in phase I/II study of ...</title><link>http://feedproxy.google.com/~r/colmed/~3/L6pi4O39rxM/cell-medica-begins-treatment-of-paediatric-patient-in-phase-iii-study-of-.aspx</link><description>&lt;div class="ExternalClass70891F6B2DB640AF9D2C0F692EEACC0B"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.pharmabiz.com/NewsDetails.aspx?aid%3D75280%26sid%3D2&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAJOAlAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNFJ0EQeJ_2dSgdFpoGWk39nIIScyg"&gt;&lt;b&gt;&lt;span style="color:#1111cc"&gt;Cell&lt;/span&gt;&lt;/b&gt;&lt;span style="color:#1111cc"&gt; Medica begins &lt;b&gt;treatment&lt;/b&gt; of paediatric patient in phase I/II study of &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;pharmabiz.com&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;&lt;b&gt;Cell&lt;/b&gt; Medic, a &lt;b&gt;cellular&lt;/b&gt; therapeutics company engaged in the development, manufacturing and marketing of T &lt;b&gt;cell&lt;/b&gt; immunotherapy approaches, has treated its first patient in the ASPIRE Trial, an early stage phase I/II clinical study investigating the safety &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/L6pi4O39rxM" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/cell-medica-begins-treatment-of-paediatric-patient-in-phase-iii-study-of-.aspx</feedburner:origLink></item><item><title>Bandra acid attack: Treating doctor explains how stem cell therapy will give ...</title><link>http://feedproxy.google.com/~r/colmed/~3/UfAIDZe1BIk/bandra-acid-attack-treating-doctor-explains-how-stem-cell-therapy-will-give-.aspx</link><description>&lt;div class="ExternalClass8DFD26C0986F480FB71E001184A27689"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.authintmail.com/news/health/bandra-acid-attack-treating-doctor-explains-how-stem-cell-therapy-will-give-her-vision&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAIOAhAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNETQfefUGBJ_M3AZppp8KqgEoxe0A"&gt;&lt;span style="color:#1111cc"&gt;Bandra acid attack: Treating doctor explains how stem &lt;b&gt;cell therapy&lt;/b&gt; will give &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Authint Mail&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;A few years ago this request would have been impossible, but thanks to the latest advances in stem &lt;b&gt;cell therapy&lt;/b&gt; it's now a very feasible possibility. We talked to ophthalmologist Dr Yasmin Bhagat who has treated a number of acid attack victims and &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/UfAIDZe1BIk" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/bandra-acid-attack-treating-doctor-explains-how-stem-cell-therapy-will-give-.aspx</feedburner:origLink></item><item><title>UCSF Research Team Develops Epilepsy Cell Therapy In Mice - The Daily Nexus</title><link>http://feedproxy.google.com/~r/colmed/~3/aMhgyEoiBqw/ucsf-research-team-develops-epilepsy-cell-therapy-in-mice-the-daily-nexus.aspx</link><description>&lt;div class="ExternalClassEFB0DE4DC5C142D48E15CB0B7D447429"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://dailynexus.com/2013-05-14/ucsf-research-team-develops-epilepsy-cell-therapy-in-mice/&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAHOAdAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNEqc6SXpwfXBvpK5DdsWSdhO8WXlw"&gt;&lt;span style="color:#1111cc"&gt;UCSF Research Team Develops Epilepsy &lt;b&gt;Cell Therapy&lt;/b&gt; In Mice - The Daily Nexus&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Daily Nexus&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;&lt;b&gt;Cell therapy&lt;/b&gt; is becoming a key component in curing this disorder, since the latest drugs only control symptoms or simply do not have any therapeutic value at all. According to the leader of the study Scott Baraban, 30 percent of all epilepsy patients &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/aMhgyEoiBqw" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/ucsf-research-team-develops-epilepsy-cell-therapy-in-mice-the-daily-nexus.aspx</feedburner:origLink></item><item><title>Research and Markets: Cell Therapy Partnering Yearbook 2013</title><link>http://feedproxy.google.com/~r/colmed/~3/FEzHaRZ_mQM/research-and-markets-cell-therapy-partnering-yearbook-2013.aspx</link><description>&lt;div class="ExternalClass479E5D44A4F64A479F1F86AA9C14089A"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.fortmilltimes.com/2013/05/09/2678140/research-and-markets-cell-therapy.html&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAGOAZAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNFlsso9LILapFylqqlEU3XyzXKGIg"&gt;&lt;span style="color:#1111cc"&gt;Research and Markets: &lt;b&gt;Cell Therapy&lt;/b&gt; Partnering Yearbook 2013&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Fort Mills Times&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;The &lt;b&gt;Cell Therapy&lt;/b&gt; Partnering Yearbook 2013 report series provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2012. Using these reports &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/FEzHaRZ_mQM" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/research-and-markets-cell-therapy-partnering-yearbook-2013.aspx</feedburner:origLink></item><item><title>Stem cell therapy a boon for patients with heart diseases</title><link>http://feedproxy.google.com/~r/colmed/~3/y-ubd81ko6c/stem-cell-therapy-a-boon-for-patients-with-heart-diseases.aspx</link><description>&lt;div class="ExternalClass74F71BA39E4A468998CFB1ED0C62784F"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://newindianexpress.com/states/kerala/Stem-cell-therapy-a-boon-for-patients-with-heart-diseases/2013/05/13/article1587672.ece&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAFOAVAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNEIZja4jPRRoNzsjFUZEvKpGGsFWA"&gt;&lt;span style="color:#1111cc"&gt;Stem &lt;b&gt;cell therapy&lt;/b&gt; a boon for patients with heart diseases&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;The New Indian Express&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;The main intention of the treatment is to ensure quality life for heart patients from the first stage of medication until the final stage of treatment. Dr Sanjay says that in stem &lt;b&gt;cell therapy&lt;/b&gt;, stem cells are collected after filtering bone marrow which &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/y-ubd81ko6c" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/stem-cell-therapy-a-boon-for-patients-with-heart-diseases.aspx</feedburner:origLink></item><item><title>Does Cell Therapy Hold The Key To Treating Stroke?</title><link>http://feedproxy.google.com/~r/colmed/~3/xmNhjT4zQbA/does-cell-therapy-hold-the-key-to-treating-stroke.aspx</link><description>&lt;div class="ExternalClassAAC3E2027BE9456BA6602599FB5A20D0"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://seekingalpha.com/article/1429761-does-cell-therapy-hold-the-key-to-treating-stroke?source%3Dgoogle_news&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAEOARAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNEAkbMfHPe-BThO63qOlLf_F_JUwA"&gt;&lt;span style="color:#1111cc"&gt;Does &lt;b&gt;Cell Therapy&lt;/b&gt; Hold The Key To Treating Stroke?&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Seeking Alpha&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;There are two small biotech companies targeting treatment of stroke with &lt;b&gt;cell therapy&lt;/b&gt; that we discuss below: Cytomedix (CMXI.OB) and Athersys (ATHX). The goal of this article is to introduce investors to the core technologies at each firm, outline each &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/xmNhjT4zQbA" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/does-cell-therapy-hold-the-key-to-treating-stroke.aspx</feedburner:origLink></item><item><title>Blind boy cured with stem cell treatment honored by Deptford Lions Club</title><link>http://feedproxy.google.com/~r/colmed/~3/Usa1rilkPJI/blind-boy-cured-with-stem-cell-treatment-honored-by-deptford-lions-club.aspx</link><description>&lt;div class="ExternalClass8550ACEFC3EE45C6B6464059AA7B716E"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.nj.com/gloucester-county/index.ssf/2013/05/deptford_lions_club_honors_boy.html&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATADOANAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNH93pgmI1WmKSKltrGkZvZ3aznpug"&gt;&lt;span style="color:#1111cc"&gt;Blind boy cured with stem &lt;b&gt;cell treatment&lt;/b&gt; honored by Deptford Lions Club&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;NJ.com&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Not many parents get excited when they notice their toddler is watching television or looking at the family dog. Then again, not many parents have traveled to China seeking stem &lt;b&gt;cell treatment&lt;/b&gt; for optic nerve hypoplasia, a congenital underdevelopment &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/Usa1rilkPJI" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/blind-boy-cured-with-stem-cell-treatment-honored-by-deptford-lions-club.aspx</feedburner:origLink></item><item><title>Cell Therapy Helps Cure Cerebral Palsy - China Daily</title><link>http://feedproxy.google.com/~r/colmed/~3/uyBuTfAfEZ8/cell-therapy-helps-cure-cerebral-palsy-china-daily.aspx</link><description>&lt;div class="ExternalClass4C0EAA1F64464263917EF61D6A6A2A26"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.chinadaily.com.cn/m/tianjin2012/2013-05/08/content_16485631.htm&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATACOAJAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNE9ypsoMKyzMiUheMI3xnd0HxovUA"&gt;&lt;b&gt;&lt;span style="color:#1111cc"&gt;Cell Therapy&lt;/span&gt;&lt;/b&gt;&lt;span style="color:#1111cc"&gt; Helps Cure Cerebral Palsy - China Daily&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;China Daily&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;&lt;b&gt;...&lt;/b&gt; body movements and sensations. With no known cure available, it affects a lot of people worldwide, including 5 million in China. While there are many life-long treatments, &lt;b&gt;cell therapy&lt;/b&gt;, an emerging alternative in recent years, seems to be more &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/uyBuTfAfEZ8" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/cell-therapy-helps-cure-cerebral-palsy-china-daily.aspx</feedburner:origLink></item><item><title>NeoStem's Subsidiary, Progenitor Cell Therapy, to Provide Autologous and ...</title><link>http://feedproxy.google.com/~r/colmed/~3/zf_4Xundrmk/neostems-subsidiary-progenitor-cell-therapy-to-provide-autologous-and-.aspx</link><description>&lt;div class="ExternalClassD82BCC0715EF4A08AE2698D22785428C"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.stockhouse.com/news/usreleasesdetail.aspx?n%3D8845359&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATABOAFAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNGL3uPHavsawlB3kV1jYfY1yjZhJA"&gt;&lt;span style="color:#1111cc"&gt;NeoStem's Subsidiary, Progenitor &lt;b&gt;Cell Therapy&lt;/b&gt;, to Provide Autologous and &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Stockhouse&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;ALLENDALE, N.J. and WASHINGTON, May 13, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS), a leader in the emerging &lt;b&gt;cellular therapy&lt;/b&gt; industry, and its subsidiary, Progenitor &lt;b&gt;Cell Therapy&lt;/b&gt;, LLC (&amp;quot;PCT&amp;quot;), an internationally recognized contract &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/zf_4Xundrmk" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/neostems-subsidiary-progenitor-cell-therapy-to-provide-autologous-and-.aspx</feedburner:origLink></item><item><title>Cell Therapy Promise Highlighted at UCSF Symposium</title><link>http://feedproxy.google.com/~r/colmed/~3/6jH4d7xAWd4/cell-therapy-promise-highlighted-at-ucsf-symposium.aspx</link><description>&lt;div class="ExternalClass6FE1A091098E45EF96859B25E1C4084C"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.ucsf.edu/news/2013/05/105811/cell-therapy-promise-highlighted-ucsf-symposium&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAAOABAwJrJjAVIAVAAWABiBWVuLVVT&amp;amp;cd=HzuHLTHS-i0&amp;amp;usg=AFQjCNEQQIrshazDPJqIi3peje4nIp_x5Q"&gt;&lt;b&gt;&lt;span style="color:#1111cc"&gt;Cell Therapy&lt;/span&gt;&lt;/b&gt;&lt;span style="color:#1111cc"&gt; Promise Highlighted at UCSF Symposium&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;UCSF News Services&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Old-line pharmaceutical companies and maturing biotech businesses both are graybeards compared to newer ventures focused on &lt;b&gt;cell therapy&lt;/b&gt;. With &lt;b&gt;cell therapy&lt;/b&gt; the drugs are alive. Cells are engineered and reprogrammed outside the body to perform &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/6jH4d7xAWd4" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/15/cell-therapy-promise-highlighted-at-ucsf-symposium.aspx</feedburner:origLink></item><item><title>Kate Pollard Receives American College of Emergency Physicians (ACEP) 2013 National Outstanding Medical Student Award</title><link>http://feedproxy.google.com/~r/colmed/~3/qj54msfaXJA/kate-pollard-receives-american-college-of-emergency-physicians-acep-2013-national-outstanding-medical-student-award.aspx</link><description>&lt;div class="ExternalClass96F22E0492194132BDD21EE49E7779F3"&gt;&lt;p&gt;​Kate Pollard will receive the American College of Emergency Physicians (ACEP) 2013 National Outstanding Medical Student Award.  One of only ten recipients of the award, she will be formally recognized this October at the Scientific Assembly held in Seattle.  The award coincides with another of Kate’s achievements, as she graduated just a few weeks ago from the College of Medicine and will pursue her residency in emergency medicine next fall at Indiana University in Indianapolis.  &lt;/p&gt;
&lt;p&gt;A native of Westfield, Indiana, Kate majored in biology at Case Western Reserve University prior to entering medical school at Ohio State.  Her decision to study medicine in Columbus was an easy one.&lt;/p&gt;
&lt;p&gt;“I chose OSU for the people.  When it comes down to it, every medical school provides a relatively similar education, but what made OSU stand out for me was, and continues to be, the people.  From the admissions staff to my classmates to our faculty, everyone truly values each other and is interested in being the best they can be.”&lt;/p&gt;
&lt;p&gt;Kate chose emergency medicine because of it allows her to care for a variety of patients with varying conditions and needs.  Each shift brings with it new challenges and firsthand interaction with patients from all walks of life who ultimately depend on her education and training for successful outcomes.  Just as her decision to attend OSU was largely based on the caliber of people on campus, Kate attributes her receiving the Outstanding Medical Student Award from ACEP to her mentors at the College.  &lt;/p&gt;
&lt;p&gt;“I think that I was selected for the award due to the unique opportunities and great mentorship that I have received from the Department of Emergency Medicine faculty during my time at OSUCOM.  I began shadowing Dr. Mark DeBard in the Emergency Department during my first year of medical school, and he introduced me to emergency medicine and has continued to serve as a great mentor to me throughout medical school.”&lt;/p&gt;
&lt;p&gt;“I also had the opportunity to explore my interests in medical education and emergency preparedness through an emergency preparedness curriculum that I developed with Dr. Nicholas Kman.  We received a Society for Academic Emergency Medicine (SAEM) Emergency Medicine Interest Group (EMIG) Grant for the curriculum and piloted it during this past school year.”&lt;/p&gt;
&lt;p&gt;Kate valued her experience at OSU to the extent that she envisions herself completing her residence in Indianapolis and eventually working at an academic medical center, teaching and mentoring future physicians.  ​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/qj54msfaXJA" height="1" width="1"/&gt;</description><pubDate>Wed, 15 May 2013 14:11:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/15/kate-pollard-receives-american-college-of-emergency-physicians-acep-2013-national-outstanding-medical-student-award.aspx</feedburner:origLink></item><item><title>2013 Distinguished Professor and Innovation Excellence Award Winners</title><link>http://feedproxy.google.com/~r/colmed/~3/qvaHHBMNags/2013-distinguished-professor-and-innovation-excellence-award-winners.aspx</link><description>&lt;div class="ExternalClass44C6CC4020D24D619ACAC0DAD1BA1218"&gt;&lt;p&gt;​The Ohio State University’s College of Medicine has begun presenting its 2013 faculty awards. Lauren Bakaletz, PhD; Ron Glaser, PhD; and David Schuller, MD, have received the College of Medicine’s Distinguished Professor awards, and Mark Moseley, MD, and Greg Wiet, MD, have received Innovation Excellence awards.&lt;/p&gt;
&lt;h2 class="ms-rteElement-H2"&gt;Lauren Bakaletz, PhD&lt;/h2&gt;
&lt;p&gt;Dr. Bakaletz is a Buckeye through and through. A full professor in the departments of Pediatrics and Otolaryngology, she attended OSU as an undergraduate, graduate and medical student and joined the OSU faculty in 1987. In a career defined by excellence and awards, a 2013 Distinguished Professor Award marks the culmination of a career that is rooted in research, teaching and mentoring.&lt;/p&gt;
&lt;p&gt;Dr. Bakaletz’s research has been published numerous times. She has developed a vaccine to minimize ear infections that is currently in clinical trial. Dr. Bakaletz is active with the National Institutes of Health, and has mentored more than 60 trainees throughout her career.&lt;/p&gt;
&lt;p&gt;In recommending her for this award, Dr. Bakaletz’s colleagues exhausted superlatives. There is a common thread that binds their glowing reviews together—they all see her as a visionary, able to think ahead and ask questions about her own research as well as the research of others.  This quest for excellence keeps Dr. Bakaletz on the leading edge of research and innovation.&lt;/p&gt;
&lt;h2 class="ms-rteElement-H2"&gt;Ron Glaser, PhD&lt;/h2&gt;
&lt;p&gt;Dr. Glaser is a professor in the Department of Molecular Virology, Immunology and Medical Genetics and director of the Institute for Behavioral Medicine Research. What defines Dr. Glaser’s career is the pioneering research he has done on the impact of stress on the immune system. In fact, his work in this area and on translational behavioral research is the preferred model of the Office of Behavioral Science at the National Institutes of Health.  &lt;/p&gt;
&lt;p&gt;During his time at Ohio State, Dr. Glaser has received numerous awards. This is actually the second time he has earned the Distinguished Professor Award—he received it first in 1995. This demonstrates a continual and relentless devotion to efforts as a teacher and a mentor to future pioneers in the field.&lt;/p&gt;
&lt;h2 class="ms-rteElement-H2"&gt;David Schuller, MD&lt;/h2&gt;
&lt;p&gt;Dr. Schuller’s career is defined by professionalism, leadership and maximum effort. A graduate of Ohio State’s College of Medicine, Dr. Schuller began as a professor in the Department of Otolaryngology – Head and Neck Surgery. After leading the OSU cancer program for nearly 20 years, in 2008 he was named vice president for Medical Center Expansion and Outreach. In this role, he drives the growth and development of the Medical Center.&lt;/p&gt;
&lt;p&gt;Known by his colleagues for his passionate work ethic and absolute commitment to excellence, Dr. Schuller is a fundamental reason why the James Cancer Hospital and Solove Research Institute has earned international recognition. In a career marked by achievement and advancement , it may be his dual commitment to The Ohio State University and the fight against cancer that ultimately distinguishes Dr. Schuller.&lt;/p&gt;
&lt;h2 class="ms-rteElement-H2"&gt;Mark Moseley, MD&lt;/h2&gt;
&lt;p&gt;A graduate of Ohio State’s College of Medicine, Dr. Moseley is an associate professor of Emergency Medicine, the assistant chief operating officer for the OUS Health System and the vice chair for Clinical Affairs. Recognized in 2010 by Business First  one of the top 40 leaders under age 40 in the community, Dr. Moseley’s ambition and passion for emergency medicine are rivaled only by his commitment to his patients.&lt;/p&gt;
&lt;p&gt;Dr. Moseley created and implemented the After Hours Clinic at Martha Morehouse. Opened in October, 2012, the Clinic came together after a year of planning, development and marketing, led by Dr. Moseley. The After Hours Clinic provides access via evening and weekend hours to folks who may not have otherwise had access to medical care. It has already proven to be cost-effective in delivering treatment.  For this accomplishment, Dr. Moseley is certainly well-deserving of the 2013 Innovation Excellence Award.&lt;/p&gt;
&lt;h2 class="ms-rteElement-H2"&gt;Greg Wiet, MD&lt;/h2&gt;
&lt;p&gt;Dr. Wiet completed his residency at The Ohio State University’s College of Medicine. He is now an associate professor of Otolaryngology and of Biomedical Informatics and the director of Pediatric Otolaryngology Research at OSU. He has mentored more than 20 students and counts more than 130 published works to his credit.&lt;/p&gt;
&lt;p&gt;What defines Dr. Wiet as an innovator is his passion for surgical simulation. Nationally and internationally, he is considered an authority on the subject. One notable innovation that Dr. Wiet fostered is a virtual temporal bone surgical simulator, which has now been studied and noted around the globe. The Innovation Excellence Award recognizes Dr. Wiet’s accomplishments, as they echo across borders.​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/qvaHHBMNags" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 18:59:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/14/2013-distinguished-professor-and-innovation-excellence-award-winners.aspx</feedburner:origLink></item><item><title>Harvard Apparatus withdraws IPO, plans NASDAQ listing via Harvard ...</title><link>http://feedproxy.google.com/~r/colmed/~3/pf02LbHBaM4/harvard-apparatus-withdraws-ipo-plans-nasdaq-listing-via-harvard-.aspx</link><description>&lt;div class="ExternalClass3214372709F24C46B112F5AF05BCCD89"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.nasdaq.com/article/harvard-apparatus-withdraws-ipo-plans-nasdaq-listing-via-harvard-bioscience-spinoff-cm243157&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAIOAhAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNEzNCWfL-EeYndHwZ3NMskqbRA6CA"&gt;&lt;span style="color:#1111cc"&gt;Harvard Apparatus withdraws IPO, plans NASDAQ listing via Harvard &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;NASDAQ&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Harvard Apparatus Regenerative Technology, a Harvard Bioscience carve-out focusing on &lt;b&gt;regenerative medicine&lt;/b&gt;, withdrew its plans for an initial public offering on Thursday citing poor market conditions. Instead, Harvard Bioscience plans to spin off 100 &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/pf02LbHBaM4" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/harvard-apparatus-withdraws-ipo-plans-nasdaq-listing-via-harvard-.aspx</feedburner:origLink></item><item><title>Conference talks stem cells</title><link>http://feedproxy.google.com/~r/colmed/~3/Q9RYpIinW2Y/conference-talks-stem-cells.aspx</link><description>&lt;div class="ExternalClassE7D8DF49683D41909CB521724203E2CC"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.ndsmcobserver.com/news/conference-talks-stem-cells-1.3039249&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAHOAdAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNGLWC6-5Ix8X07Z5TRHYIRAbl7Qng"&gt;&lt;span style="color:#1111cc"&gt;Conference talks stem cells&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Observer Online&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;The conference, titled “&lt;b&gt;Regenerative Medicine&lt;/b&gt;: A Fundamental Shift in Science and Culture,” was intended to promote awareness of adult stem cell research and its potential and implications for the future of medicine. Juniors Rebecca Marton and Kristin &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/Q9RYpIinW2Y" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/conference-talks-stem-cells.aspx</feedburner:origLink></item><item><title>BioLife Solutions licenses specific areas of intellectual property to Janssen</title><link>http://feedproxy.google.com/~r/colmed/~3/-YLD6G8hjS4/biolife-solutions-licenses-specific-areas-of-intellectual-property-to-janssen.aspx</link><description>&lt;div class="ExternalClassEC9E18E0B8054C1BB0D559003D3BDA70"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.news-medical.net/news/20130502/BioLife-Solutions-licenses-specific-areas-of-intellectual-property-to-Janssen.aspx&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAGOAZAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNHX_t5U_JTLf0LvBZ0obuEEMw2B2g"&gt;&lt;span style="color:#1111cc"&gt;BioLife Solutions licenses specific areas of intellectual property to Janssen&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;News-Medical.net&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;This is a critical component in optimizing the biopreservation economics of emerging &lt;b&gt;regenerative medicine&lt;/b&gt; therapies where efficient, scalable, and consistent product delivery to a worldwide clinical patient population will strongly dictate commercial &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/-YLD6G8hjS4" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/biolife-solutions-licenses-specific-areas-of-intellectual-property-to-janssen.aspx</feedburner:origLink></item><item><title>ACell Receives SMARTCAP award from NASA-funded Space Research Institute</title><link>http://feedproxy.google.com/~r/colmed/~3/jHKjl3ajybM/acell-receives-smartcap-award-from-nasa-funded-space-research-institute.aspx</link><description>&lt;div class="ExternalClass0CF9995F90FE45DB97373F0EDA84774D"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.sacbee.com/2013/05/01/5385836/acell-receives-smartcap-award.html&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAFOAVAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNG9yHWH9gP4LJovl3CQH924wkpTYw"&gt;&lt;span style="color:#1111cc"&gt;ACell Receives SMARTCAP award from NASA-funded Space Research Institute&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Sacramento Bee&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;COLUMBIA, Md., May 1, 2013 -- /PRNewswire/ -- ACell, Inc., a leading developer of next-generation &lt;b&gt;regenerative medicine&lt;/b&gt; products, announced today that it has received the Space Medicine and Related Technologies Commercialization Assistance Program &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/jHKjl3ajybM" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/acell-receives-smartcap-award-from-nasa-funded-space-research-institute.aspx</feedburner:origLink></item><item><title>HBIO Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc ...</title><link>http://feedproxy.google.com/~r/colmed/~3/qdEPtbdDngg/hbio-affirms-plan-to-spin-off-harvard-apparatus-regenerative-technology-inc-.aspx</link><description>&lt;div class="ExternalClassE0A86AF7FE384C149A4EE4274A40D23F"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://online.wsj.com/article/PR-CO-20130501-913327.html&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAEOARAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNEtIgERb0yJPZ1chDZEKyo6hPAChg"&gt;&lt;span style="color:#1111cc"&gt;HBIO Affirms Plan to Spin-Off Harvard Apparatus &lt;b&gt;Regenerative&lt;/b&gt; Technology, Inc &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Wall Street Journal&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;HOLLISTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and &lt;b&gt;regenerative medicine&lt;/b&gt;, today announced that it &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/qdEPtbdDngg" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/hbio-affirms-plan-to-spin-off-harvard-apparatus-regenerative-technology-inc-.aspx</feedburner:origLink></item><item><title>Tamil Nadu vet varsity to get stem cell research centre</title><link>http://feedproxy.google.com/~r/colmed/~3/dkOV6Tol7wo/tamil-nadu-vet-varsity-to-get-stem-cell-research-centre.aspx</link><description>&lt;div class="ExternalClassDACD8EFFF11A428090FC50883649A226"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://timesofindia.indiatimes.com/City/Chennai/Tamil-Nadu-vet-varsity-to-get-stem-cell-research-centre/articleshow/19921716.cms&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATADOANAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNFka3H4IbnucGDLf8Id808SxsLSWg"&gt;&lt;span style="color:#1111cc"&gt;Tamil Nadu vet varsity to get stem cell research centre&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Times of India&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Jayalalithaa said that &lt;b&gt;regenerative medicine&lt;/b&gt;, a new medical procedure, would also be implemented in the state to prevent and protect livestock from various diseases. &lt;b&gt;Regenerative medicine&lt;/b&gt; is the process of replacing stem cells to restore or establish &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/dkOV6Tol7wo" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/tamil-nadu-vet-varsity-to-get-stem-cell-research-centre.aspx</feedburner:origLink></item><item><title>Photo Release - - Harvard Apparatus Regenerative Technology's " InBreath ...</title><link>http://feedproxy.google.com/~r/colmed/~3/nny-uMB8bK8/photo-release-harvard-apparatus-regenerative-technologys-quote-inbreath-.aspx</link><description>&lt;div class="ExternalClassF6092A445A5040BF83B48CA5D2E885C3"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.marketwatch.com/story/photo-release-harvard-apparatus-regenerative-technologys-inbreath-scaffold-and-bioreactor-used-in-first-us-transplant-of-a-regenerated-trachea-2013-04-30&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATACOAJAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNFjFK6jGx_3vtS9chPLHCVV8ptuJQ"&gt;&lt;span style="color:#1111cc"&gt;Photo Release - - Harvard Apparatus &lt;b&gt;Regenerative&lt;/b&gt; Technology's &amp;quot; InBreath &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;MarketWatch&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;HOLLISTON, Apr 30, 2013 (GLOBE NEWSWIRE via COMTEX) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) , a global developer, manufacturer and marketer of a broad range of tools to advance life science research and &lt;b&gt;regenerative medicine&lt;/b&gt;, announces that &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/nny-uMB8bK8" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/photo-release-harvard-apparatus-regenerative-technologys-quote-inbreath-.aspx</feedburner:origLink></item><item><title>HBIO Affirms Plan to Spin - Off Harvard Apparatus Regenerative Technology ...</title><link>http://feedproxy.google.com/~r/colmed/~3/ReTaRDA9GTk/hbio-affirms-plan-to-spin-off-harvard-apparatus-regenerative-technology-.aspx</link><description>&lt;div class="ExternalClassEAF2EC789E9B48EB8B49041EF6F9ED63"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.marketwatch.com/story/hbio-affirms-plan-to-spin-off-harvard-apparatus-regenerative-technology-inc-and-announces-its-intended-path-forward-2013-05-01&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATABOAFAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNGL3rJBz4yBskxJ5HRw0bDdtNTj4g"&gt;&lt;span style="color:#1111cc"&gt;HBIO Affirms Plan to Spin - Off Harvard Apparatus &lt;b&gt;Regenerative&lt;/b&gt; Technology &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;MarketWatch&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;Harvard Bioscience intends to effect the separation of its &lt;b&gt;regenerative medicine&lt;/b&gt; business through the spin-off of 100% of HART's common stock to Harvard Bioscience stockholders in a pro-rata, tax-free dividend. Prior to such spin-off, Harvard &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/ReTaRDA9GTk" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/hbio-affirms-plan-to-spin-off-harvard-apparatus-regenerative-technology-.aspx</feedburner:origLink></item><item><title>TN to introduce regenerative medicine in veterinary care</title><link>http://feedproxy.google.com/~r/colmed/~3/osqQ9MlUdE8/tn-to-introduce-regenerative-medicine-in-veterinary-care.aspx</link><description>&lt;div class="ExternalClass222797354D04468A9F735F2F131E4508"&gt;&lt;p&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;a href="http://www.google.com/url?sa=X&amp;amp;q=http://www.business-standard.com/article/pti-stories/tn-to-introduce-regenerative-medicine-in-veterinary-care-113050600313_1.html&amp;amp;ct=ga&amp;amp;cad=CAEQAxgAIAAoATAAOABAhqWkjAVIAVAAWABiBWVuLVVT&amp;amp;cd=7Oqn7URBfj4&amp;amp;usg=AFQjCNGRwPAttc-Dv0vf_wbundc3LZIe5w"&gt;&lt;span style="color:#1111cc"&gt;TN to introduce &lt;b&gt;regenerative medicine&lt;/b&gt; in veterinary care&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;span class="MsoHyperlink"&gt;&lt;span style="font-family:'times new roman', 'serif';color:#777777;font-size:10pt;text-decoration:none;text-underline:none"&gt;&lt;u&gt;Business Standard&lt;/u&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:10pt"&gt;&lt;br /&gt;In a first-of-its-kind initiative in the country, the Tamil Nadu government would introduce '&lt;b&gt;regenerative medicine&lt;/b&gt;' in veterinary care and would set up a research centre capitalising on stem cells. Making a statement in the Assembly, Chief Minister J &lt;b&gt;...&lt;/b&gt;&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/osqQ9MlUdE8" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 15:36:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/14/tn-to-introduce-regenerative-medicine-in-veterinary-care.aspx</feedburner:origLink></item><item><title>Congratulations Research Day Award Winners!</title><link>http://feedproxy.google.com/~r/colmed/~3/FWqSt4XWzh0/congratulations-research-day-award-winners.aspx</link><description>&lt;div class="ExternalClassBEE2B0486B5949A485BFE21532BE448A"&gt;Research Day provides an opportunity for researchers in training at OSU Wexner Medical Center to present their biomedical research in a public forum and to compete for travel awards given for outstanding work. This group includes trainees at all levels of programming, including graduate, undergraduate, medical and MD/PhD students, as well as postdoctoral fellows and researchers and clinical residents and fellows. Research Day also presents an opportunity for colleagues and visitors to learn about the cutting edge research occuring at Ohio State.&lt;p&gt;&lt;/p&gt;
&lt;div&gt;More than 300 posters representing a wide array of research topics are displayed throughout the day, with presenters on hand to discuss their projects and research findings with visitors and guests. Faculty judges review two or more poster presentations and make the final selections for the awards.&lt;/div&gt;
&lt;div&gt;&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;Below is a full list of award winners, congratulations everyone!&lt;/div&gt;
&lt;div&gt;&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;Brian Hurwitz&lt;/div&gt;
&lt;div&gt;Tyler Spata&lt;/div&gt;
&lt;div&gt;Robert Plews&lt;/div&gt;
&lt;div&gt;Carmen Quatman&lt;/div&gt;
&lt;div&gt;Thomas Mace&lt;/div&gt;
&lt;div&gt;Oliver Voss&lt;/div&gt;
&lt;div&gt;Michael Carruthers&lt;/div&gt;
&lt;div&gt;Duaa Dakhlallah&lt;/div&gt;
&lt;div&gt;Edward Briercheck&lt;/div&gt;
&lt;div&gt;Bin Ni&lt;/div&gt;
&lt;div&gt;Nima Milani-Nejad&lt;/div&gt;
&lt;div&gt;Audrey Lloyd&lt;/div&gt;
&lt;div&gt;Andrew Stiff&lt;/div&gt;
&lt;div&gt;Amy Somerset&lt;/div&gt;
&lt;div&gt;Sarada Eleswarpu&lt;/div&gt;
&lt;div&gt;Yao-Wen Cheng&lt;/div&gt;
&lt;div&gt;James Vargo&lt;/div&gt;
&lt;div&gt;Ana De Roo&lt;/div&gt;
&lt;div&gt;Tim Richmond&lt;/div&gt;
&lt;div&gt;Nicholas Polley&lt;/div&gt;
&lt;div&gt;Kavya Manu&lt;/div&gt;
&lt;div&gt;Loic Tchokouani&lt;/div&gt;
&lt;div&gt;Prashanth Swamy&lt;/div&gt;
&lt;div&gt;Jacqueline Domire&lt;/div&gt;
&lt;div&gt;W Hans Meisen&lt;/div&gt;
&lt;div&gt;Katie Thies&lt;/div&gt;
&lt;div&gt;Sarah Fritz&lt;/div&gt;
&lt;div&gt;Geoffrey Gonzalez-Escobedo&lt;/div&gt;
&lt;div&gt;Chelsea Bolyard&lt;/div&gt;
&lt;div&gt;Eusondia Arnett​&lt;/div&gt;
​&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/FWqSt4XWzh0" height="1" width="1"/&gt;</description><pubDate>Tue, 14 May 2013 13:34:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/14/congratulations-research-day-award-winners.aspx</feedburner:origLink></item><item><title>Dr. Dan Wozniak and Dr. Chandan Sen - "Ohio State Researchers Receive $2.1M to Study Wound Care Treatment."</title><link>http://feedproxy.google.com/~r/colmed/~3/Qh8ADQiFYtQ/dr-dan-wozniak-and-dr-chandan-sen-quote-ohio-state-researchers-receive-2-1m-to-study-wound-care-treatment-quote.aspx</link><description>&lt;div class="ExternalClass5AFEF1B39226432DADA1ED75976A1BAB"&gt;&lt;p&gt;Dr. Dan Wozniak, professor of Microbiology, Microbial Immunity and Infection, and member of the Center for Microbial Interface Biology and Dr. Chandan Sen, professor and vice chair for research in Ohio State's Department of Surgery received $2.1 million to study wound care treatment. The full story can be read at &lt;a href="http://medicalcenter.osu.edu/mediaroom/releases/Pages/Ohio-State-Researchers-Receive-$2.1M-to-Study-Wound-Care-Treatment.aspx"&gt;http://medicalcenter.osu.edu/mediaroom/releases/Pages/Ohio-State-Researchers-Receive-$2.1M-to-Study-Wound-Care-Treatment.aspx&lt;/a&gt;. ​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/Qh8ADQiFYtQ" height="1" width="1"/&gt;</description><pubDate>Fri, 10 May 2013 20:12:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/mii/events/news/archive/2013/05/10/dr-dan-wozniak-and-dr-chandan-sen-quote-ohio-state-researchers-receive-2-1m-to-study-wound-care-treatment-quote.aspx</feedburner:origLink></item><item><title>Dr. Jordi Torrelles - "Improving diagnosis of tuberculosis" to conduct public health research in Guatemala.</title><link>http://feedproxy.google.com/~r/colmed/~3/2R664DM3oG0/dr-jordi-torrelles-quote-improving-diagnosis-of-tuberculosis-quote-to-conduct-public-health-research-in-guatemala-.aspx</link><description>&lt;div class="ExternalClass268A36034B6643E4A9898F528C1586CB"&gt;&lt;p&gt;Congratulations for Dr. Jordi Torrelles for earning the PHPID track Gateway Research Grant for International Infectious Disease work. ​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/2R664DM3oG0" height="1" width="1"/&gt;</description><pubDate>Thu, 09 May 2013 18:16:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/mii/events/news/archive/2013/05/09/dr-jordi-torrelles-quote-improving-diagnosis-of-tuberculosis-quote-to-conduct-public-health-research-in-guatemala-.aspx</feedburner:origLink></item><item><title>Dr.Joesph Wu presentation on "Cardiac iPSCs for Disease Modeling, Drug Screening, and Cell Therapy”   </title><link>http://feedproxy.google.com/~r/colmed/~3/FZhoVAxI-To/dr-joesph-wu-presentation-on-quote-cardiac-ipscs-for-disease-modeling-drug-screening-and-cell-therapy%e2%80%9d-1.aspx</link><description>&lt;div class="ExternalClass728F0C3906D8427F861B18316CF123E0"&gt;&lt;div class="ExternalClass63BE43172F4944FBAA0E4AA2448FDE4A ms-rteFontSize-2"&gt;&lt;p&gt;&lt;span&gt;Dr. Joseph Wu from Stanford University School of Medicine will give a presentation on “Cardiac iPSCs for Disease Modeling, Drug Screening, and Cell Therapy”at DHLRI RIP on May 3rd, 2013. &lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/FZhoVAxI-To" height="1" width="1"/&gt;</description><pubDate>Thu, 09 May 2013 17:34:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/09/dr-joesph-wu-presentation-on-quote-cardiac-ipscs-for-disease-modeling-drug-screening-and-cell-therapy%e2%80%9d-1.aspx</feedburner:origLink></item><item><title>​Seven 2013 Graduates Showcase OSU's Seven Unmatched Health Sciences Colleges</title><link>http://feedproxy.google.com/~r/colmed/~3/8VLQiVfOP5Y/seven-amazing-2013-graduates-showcase-ohio-state%e2%80%99s-seven-unmatched-health-sciences-colleges.aspx</link><description>&lt;div class="ExternalClass2EC9DBE5DE6F4B8CA11D18CAE76E1E2A"&gt;&lt;span style="font-size:8pt"&gt;&lt;em&gt;By Kathy Baird&lt;/em&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;In their free time, they may be found winning a bodybuilding competition, biking cross-country for charity, or solving Sudoku puzzles.
&lt;p&gt;Professionally, they may ​be providing charity treatment for other continents, exploring the health of farm-raised fish, or even studying the mechanics of dental implants.&lt;/p&gt;
&lt;p&gt;They represent seven outstanding spring 2013 Ohio State graduates, one from each of the health sciences colleges. Each graduate showcases the deep and broad range of interests and opportunities found on Ohio State’s one-of-a-kind health sciences campus.&lt;/p&gt;
&lt;p&gt;Ohio State includes the colleges of Dentistry, Medicine, Nursing, Optometry, Pharmacy, Public Health, and Veterinary Medicine, making it the only campus in the country to combine seven health sciences colleges and a comprehensive medical center. &lt;/p&gt;
&lt;p&gt;These seven selected graduates’ stories provide an inside look at their seven colleges’ combined impact. &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;h3 class="ms-rteElement-H3"&gt;Blazing new trails- Eliza Beal, MD, College of Medicine&lt;/h3&gt;
&lt;div&gt;Blazing trails is nothing new for Eliza Beal, recent Doctor of Medicine graduate from the College of Medicine. In the weeks surrounding graduation, Beal is blazing a 3,400-mile bike ride across the country as CEO of Ride for World Health, a local non-profit founded and run by Ohio State medical students.&lt;/div&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;The trip, from March 20 to May 12, includes stops in 40 cities to conduct youth educational programs. Funds raised by riders support two overseas medical charities: Empower and Advance and Village Health Works.&lt;/p&gt;
&lt;p&gt;“The real reason I got involved with Ride for World Health is the global health aspects,” Beal said. “The cycling is just a fun bonus.”&lt;/p&gt;
&lt;p&gt;She also broke new ground during medical school when she created a new local chapter of the Institute for Healthcare Improvement Open School, which focuses on continuous improvement of medical processes for maximum patient safety.&lt;/p&gt;
&lt;p&gt;In another pivotal experience this year, she spent four weeks at a private hospital in Zambia to provide corrective surgery for children with disabilities. &lt;/p&gt;
&lt;p&gt;“There’s so much teamwork- opportunity to get involved with other students, students in other health professions, and students from all over the country,” Beal said.&lt;/p&gt;
&lt;p&gt;For her work, Beal has won a long list of awards, including two for organizational leadership and another for her 100-plus volunteer hours with Suicide Prevention Services. &lt;/p&gt;
&lt;p&gt;Originally, Beal planned a career in emergency medicine, having worked as an Emergency Medical Technician in her hometown. However, things changed.&lt;/p&gt;
&lt;p&gt;“I stepped into the operating room for the first time and I was hooked,” she said. “I wanted to do surgery.”&lt;/p&gt;
&lt;p&gt;With surgery, Beal wants to combine her work in quality improvement to pursue a career in academic medicine.&lt;/p&gt;
&lt;p&gt;“I’m interested in doing liver and kidney transplants,” she said. “Abdominal organ transplants have one of the greatest potential impacts on the patient’s quality of life.”&lt;/p&gt;
&lt;p&gt;This summer, Beal will take a major step toward those goals when she enters a six-year residency in general surgery at Wexner Medical Center.&lt;/p&gt;
&lt;h3 class="ms-rteElement-H3"&gt;Engineering Smiles- Joseph Pittman, DDS, College of Dentistry&lt;/h3&gt;
&lt;p&gt;For Joseph Pittman building smiles was a natural fit for his mechanical engineering background. Pittman is a recent Doctor of Dental Science graduate from the College of Dentistry and also holds a bachelor’s degree in mechanical engineering from Ohio State. Pittman said he sought out dentistry for its opportunities to work with people, work with his hands, and run his own business.&lt;/p&gt;
&lt;p&gt;Pittman’s main focus has been research. He won first place and second place Dean’s Award for Excellence in Research from the College of Dentistry in two successive years, and presented his winning research at dental conferences across the country. &lt;/p&gt;
&lt;p&gt;While working under the direction of Do-Gyoon Kim, PhD, assistant professor of orthodontics, he conducted a study on dental mini-implant stability based on bone density. He also gained practical experience while interning for Procter &amp;amp; Gamble. There, he did research on cold remedy formulations and conducted consumer research interviews about toothpaste.&lt;/p&gt;
&lt;p&gt;Community service has also been an ongoing commitment for Pittman. He volunteered in villages surrounding Kampala, Uganda where he worked without electricity for six days to do extractions for people without regular access to dental care.  Currently, he volunteers monthly to provide dental care at a free clinic for underserved patients in Columbus. &lt;/p&gt;
&lt;p&gt;This summer Pittman will volunteer for two months at a dental clinic in Cuzco, Peru. Next fall he will enter a three-year orthodontics master’s degree program at the University of North Carolina, where he will combine his mechanical abilities with his dentistry skills.&lt;/p&gt;
&lt;h3 class="ms-rteElement-H3"&gt;Prizing Fitness- Samantha Bossert, BSN, College of Nursing&lt;/h3&gt;
&lt;p&gt;Knowing that fitness and health are closely linked, Samantha Bossert leads the quest for wellness by example. Bossert, a graduate from the College of Nursing , is a former personal trainer who closely monitors her own diet and exercise to compete in major fitness shows such as The Arnold Classic held in Columbus.&lt;/p&gt;
&lt;p&gt;“Competition is an opportunity for me to see what I can do with my body and see myself at an optimum state of health,” Bossert said.&lt;/p&gt;
&lt;p&gt;She hopes to share this knowledge of fitness and health with future patients as she pursues her nursing career in the Columbus area.Personal tragedy is what led her to career decision. When she was a high school freshman, her father, an orthopedic surgeon, was involved in a motorcycle accident and became paralyzed from the waist down. Initially, he was diagnosed as a quadriplegic, but extensive rehabilitation helped him regain much hand function. &lt;/p&gt;
&lt;p&gt;“That really made me want to take another step towards healthcare,” Bossert said. “I realized nursing was definitely my calling.” &lt;/p&gt;
&lt;p&gt;While not sure the precise direction her nursing career will take, Bossert especially enjoyed her training experience in labor and delivery.&lt;/p&gt;
&lt;p&gt;“I love being a part of a family’s life when they’re bringing new life into the world,” she said.&lt;/p&gt;
&lt;h3 class="ms-rteElement-H3"&gt;Unfailing focus- Masoud Nafey, OD, College of Optometry&lt;/h3&gt;
&lt;p&gt;Hard work, commitment, and a love of people go hand-in-hand for Masoud Nafey, recent graduate from the College of Optometry. &lt;/p&gt;
&lt;p&gt;Since childhood, Nafey said he knew he wanted to be a doctor.&lt;/p&gt;
&lt;p&gt;“I wanted to focus on something that can always make a difference,” he said.&lt;/p&gt;
&lt;p&gt;Nafey’s determination to succeed had early roots. He was born in Afghanistan the year the Soviets invaded his country. His parents, a biology teacher and businessman, had to leave everything, he said.&lt;/p&gt;
&lt;p&gt;“My main motivation through life is my parents,” he said. “My parents sacrificed so much for me. That is why I pushed myself.”&lt;/p&gt;
&lt;p&gt;At Ohio State, Nafey served as College of Optometry class president for all four years, working to help classmates succeed. On the patient side he did residencies at a Veterans Affairs clinic in Tucson, Ariz., and a laser surgery center in Oak Brook, Ill.. On a service trip to Bolivia, his group gave 1,000 eye exams in four days.&lt;/p&gt;
&lt;p&gt;For his academic, professional, and extracurricular achievements, he received a national student award from the National Optometric Association and a statewide honor from the Ohio Optometric Foundation.&lt;/p&gt;
&lt;p&gt;Now, with the completion of his professional studies, he plans to enter optometry practice in the northern California Bay Area, near his hometown.&lt;/p&gt;
&lt;p&gt;“My first goal is to buy my parents a house, and then I’ll start worrying about myself,” he said. “For me, being an optometrist is a gift. This my opportunity to give the gift back.”&lt;/p&gt;
&lt;h3 class="ms-rteElement-H3"&gt;A new take on teaching- David Matthews, PharmD, College of Pharmacy&lt;/h3&gt;
&lt;p&gt;Teaching is a passion for David Matthews a recent graduate from the College of Pharmacy with a Doctor of Pharmacy degree.&lt;/p&gt;
&lt;p&gt;Matthews holds a degree in education from Xavier University and taught sixth grade math and social studies for a year before entering pharmacy school.&lt;/p&gt;
&lt;p&gt;This year he won the national championship at the American Pharmacists Association Academy of Student Pharmacists Patient Counseling Competition, where individual student pharmacists counsel a mock patient about a prescribed medication. He also co-chaired the committee of pharmacy students who work with the Central Ohio Poison Center to present the Be Poison Smart program in classrooms.&lt;/p&gt;
&lt;p&gt;“Teaching comes in many different forms,” Matthews said. “I’ve always been passionate about teaching and wanted to teach from a very young age.”&lt;/p&gt;
&lt;p&gt;Pharmacy also piqued his interest early. As a child watching his grandparents take multiple medications, he was interested in how those medications worked in the body. &lt;/p&gt;
&lt;p&gt;This summer, Matthews will enter an Ohio State pharmacy residency, teaching in the College of Pharmacy while also doing clinical work and research. Even his clinical work will offer an opportunity for teaching as he counsels ambulatory care center patients about medications, recommends medications to physicians, and mentors pharmacy students.&lt;/p&gt;
&lt;p&gt;“Education is where my passion is, and what I want to do with pharmacy ultimately is not just practice, but teach others,” he said. “It’s been great because I’ve been able to incorporate the best of both worlds, doing the teaching and the pharmacy together.”&lt;/p&gt;
&lt;h3 class="ms-rteElement-H3"&gt;Solving puzzles- Gary Klase, MS, College of Public Health&lt;/h3&gt;
&lt;p&gt;Gary Klase, a recent graduate from the College of Public Health with a Master of Science in Public Health, likes solving puzzles. Whether the challenge is a chemistry equation, Sudoku, or a public health issue, Klase said the solution process is much the same.&lt;/p&gt;
&lt;p&gt;He said he takes stock of the various pieces, focuses on one section of the problem at a time, and draws on imagination to see how the various parts connect to create a full solution. &lt;/p&gt;
&lt;p&gt;Klase’s main interest in public health is water. He worked as a lab assistant at Ohio State’s Stone Lab on Lake Erie and interned at Ohio Agricultural Research and Development Center. &lt;/p&gt;
&lt;p&gt;“I like to be involved in research looking at the relationship between environmental sustainability and human health,” Klase said. &lt;/p&gt;
&lt;p&gt;Klase also spent 10 weeks last summer in China as a visiting researcher working with a group from the Chinese Centers for Disease Control and Prevention. He conducted a biological field survey in Chinese fishponds to investigate a human liver parasite that is transmitted by eating undercooked fish. &lt;/p&gt;
&lt;p&gt;Klase may one day pursue an academic career, but right now he plans to put theory to work to solve environmental problems and improve public health. He said his main focus will be developing countries.&lt;/p&gt;
&lt;p&gt;“If we can develop a low-energy solution there, we can use those ideas to reduce our energy costs,” he said. “It will have to be done in small pieces and by slowly putting the pieces together.” &lt;/p&gt;
&lt;p&gt;That is just the kind of puzzle that Klase enjoys.&lt;/p&gt;
&lt;h3 class="ms-rteElement-H3"&gt;Deep insights into fish- Stephen Reichley, DVM, College of Veterinary Medicine&lt;/h3&gt;
&lt;p&gt;Caring for animals took an unexpected turn for Stephen Reichley, recent graduate from the College of Veterinary Medicine with a Doctor of Veterinary Medicine degree. &lt;/p&gt;
&lt;p&gt;Attracted by the investigative nature of veterinary medicine, Reichley first thought he would work with horses. However, after an in-class mention of aquaculture, his career interests went in a new direction.&lt;/p&gt;
&lt;p&gt;Reichley arranged an internship with the Ohio Department of Agriculture’s Aquaculture Department and worked with Ohio fish farmers to learn about their operations and challenges. Later internships took him across the United States and the world.&lt;/p&gt;
&lt;p&gt;“There’s a lot we don’t know about fish,” Reichley said. “There are diseases for which we don’t know the cause. There’s a lot of room for improvement.”&lt;/p&gt;
&lt;p&gt;Reichley said we need to help the commercial herd of fish since they are so valuable to diets, but we also need to note the effects that we have on the wild populations.&lt;/p&gt;
&lt;p&gt;With such interests in mind, Reichley will soon enter Mississippi State University to pursue a Ph.D. in Veterinary Medical Science with a focus on Aquatic Animal Medicine and Epidemiology, and will also serve as a graduate research assistant and clinical instructor. Then he hopes to do government or nonprofit work, possibly in the regulatory area.&lt;/p&gt;
&lt;p&gt;“As the ultimate goal, I want to do international work, whether for a U.S. government organization, for an intergovernmental agency, or in the private sector,” Reichley said.​&lt;/p&gt;&lt;/div&gt;
​&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/8VLQiVfOP5Y" height="1" width="1"/&gt;</description><pubDate>Wed, 08 May 2013 15:47:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/08/seven-amazing-2013-graduates-showcase-ohio-state%e2%80%99s-seven-unmatched-health-sciences-colleges.aspx</feedburner:origLink></item><item><title>Convocation Honors the Class of 2013</title><link>http://feedproxy.google.com/~r/colmed/~3/K21YOJJ_n4s/convocation-honors-the-class-of-2013.aspx</link><description>&lt;div class="ExternalClass22800FF2702143A696730AD614A67638"&gt;&lt;p&gt;​&lt;img src="/news/Lists/Photos/convoohio.JPG" alt="convoohio.JPG" class="ms-rtePosition-2 ms-rteImage-2" style="margin:5px" /&gt;Beginning with a procession of faculty and graduates across the Oval of The Ohio State University, the College of Medicine Convocation is the culmination of 4 years of hard work and celebrates the transformation of student to physician. Convocation also features an address by the Professor of Year, who has been chosen for this highest teaching honor by the graduating class.&lt;/p&gt;
&lt;p&gt;To place their hoods, students may choose an OSUCOM faculty member (MD/DO/PhD) or any other physician who has been important in their choice to become a  physician or who has helped them along the way. Students can invite as many family and friends as they want to this important event held in OSU's Mershon Auditorium.&lt;/p&gt;
&lt;p&gt;To view a complete list of graduates and award winners, please view the &lt;a href="/SiteCollectionDocuments/Graduation%20Program%202013%20FINAL.pdf" target="_blank"&gt;2013 Convocation Program&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/K21YOJJ_n4s" height="1" width="1"/&gt;</description><pubDate>Tue, 07 May 2013 15:50:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/07/convocation-honors-the-class-of-2013.aspx</feedburner:origLink></item><item><title>Biomedical Science Major Prepares for the Next Level</title><link>http://feedproxy.google.com/~r/colmed/~3/Ar8_4UKf1GA/biomedical-science-major-prepares-for-the-next-level.aspx</link><description>&lt;div class="ExternalClass9AA7AC8644E54814B9F165784C9C6944"&gt;&lt;p&gt;​&lt;img src="/news/Lists/Photos/jarjour.png" alt="jarjour.png" class="ms-rtePosition-1 ms-rteImage-2" style="margin:5px;height:253px;width:176px" /&gt;Nicholas Jarjour is set to graduate from the Biomedical Science Major (BMS), a research-intensive undergraduate major offered by the College of Medicine and the Wexner Medical Center.  A native of Charlottesville, Virginia, Nicholas chose OSU over the University of Virginia.  The many opportunities to pursue research tipped the scales in favor of OSU, so Nicholas applied and gained admission to the BMS program as a freshman.  Four years later, he is preparing to move onto graduate school at Washington University in St. Louis.&lt;/p&gt;
&lt;p&gt;Before accepting the offer from Washington’s immunology program, however, he considered competing offers from Johns Hopkins University, Stanford University, the University of Pennsylvania, and the University of Michigan.  Nicholas credits the BMS program at OSU as the key factor in gaining admission to and preparing him to study and pursue a PhD at these prestigious institutions.&lt;/p&gt;
&lt;p&gt;“The Biomedical Science major was absolutely essential to my success in a number of ways.  The most obvious is its deep commitment to research.  I spent over three and a half years working in two different labs.  Extensive research is highly valued by graduate schools because it prepares students to succeed during their pursuit of advanced degrees and opens their eyes to the challenging but rewarding nature of laboratory science.”&lt;/p&gt;
&lt;p&gt;Much of the laboratory experience Nicholas gained at OSU occurred under the tutelage of Dr. John Gunn, the Director of the BMS program.  Dr. Gunn instructed Nicholas in the lab and the classroom, but he also provided guidance when Nicholas was preparing to interview and ultimately choose a graduate school.  With a PhD from the University of Maryland and post-doctoral work at Harvard Medical School, Dr. Gunn has been at OSU for the past 10 years.  He reflects fondly on his time teaching and mentoring Nicholas.&lt;/p&gt;
&lt;p&gt;“I first met Nicholas when he was a freshman.  He worked in my laboratory for two years.  Nicholas is perhaps the most well read and inquisitive undergraduate student I have ever met.  He is highly motivated and questions everything. His knowledge of immunology is equivalent to that of senior graduate students.”&lt;/p&gt;
&lt;p&gt;Armed with the knowledge gained at OSU through the rigorous BMS curriculum, Nicholas will study the immune system specifically in contexts of infection, cancer and autoimmune disease at Washington University.  After his time in the laboratory of Dr. Gunn, he spent over a year in the immunology laboratory of Dr. Amy Lovett-Racke, where he gained additional valuable experience in his field of interest. He moves onto graduate school with a great deal of gratitude for his time at OSU.&lt;/p&gt;
&lt;p&gt;“Truly, Biomedical Science at The Ohio State University provides an unmatched opportunity for students to prepare for their future careers in medicine.”&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/Ar8_4UKf1GA" height="1" width="1"/&gt;</description><pubDate>Tue, 07 May 2013 15:38:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/news/archive/2013/05/07/biomedical-science-major-prepares-for-the-next-level.aspx</feedburner:origLink></item><item><title>Congratulations Victoria Dominguez on co-authoring a newly released paper!</title><link>http://feedproxy.google.com/~r/colmed/~3/6eSMuVSFaY0/congratulations-victoria-dominguez-on-co-authoring-a-newly-release-paper.aspx</link><description>&lt;div class="ExternalClass363FD896C47F41C2A7A0BE08F6B3640B"&gt;&lt;p&gt;&lt;em&gt;Scaling of Haversian Canal Surface Area to Secondary Osteon Bone Volume In Ribs and Limb Bones&lt;/em&gt; Co-Arthored by Victoria Dominguez, an Anatomy PhD student, has recently been published in the &lt;em&gt;American Journal of Physical Anthropology&lt;/em&gt;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Abstract:&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Studies of secondary osteons in ribs have provided a great deal of what is known about remodeling dynamics. Compared with limb bones, ribs are metabollically more active and sensitive to hormonal changes, and receive frequent low-strain loading. Optimization for calcium exchange in rib osteons might be achieved without incurring a significant reduction in safety factor by disproportionally increasing central canal size with increased osteon size (positive allometry). By contrast, greater mechanical loads on limb bones might favor reducing deleterious consequences of intracortical porosity by decreasing osteon canal size with incresed osteon size (negative allometry). Evidence of this metabolic/mechanical dichotomy between ribs and limb bones was sought by examing relationships between Haversian canal serface area (BS, osteon Haversian canal perimeter, HC.Pm) and bone volume (BV, osteonal wall area, B.Ar) in a broad size range of mature (quienscent) osteons from adult human limb bones and ribs (modern and medieval) and various adult and subadult non-human limb bones and ribs. Reduced major axis (RMA) and least-squares (LS) regressions of HC.Pm/B.Ar data show that rib and limb osteons cannot be distinguished by dimensional allometry of these parameters. Although four of the five rib groups showed positive allometry in terms of the RMA slopes, nearly 50% of the adult limb bone groups also showed positive allometry when negative allometry was expected. Consequently, our results fail to provide clear evidence that BS/BV scaling reflects a rib versus limb bone dichotomy wherby calcium exchange might be preferntially enhanced in rib osteons.&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/6eSMuVSFaY0" height="1" width="1"/&gt;</description><pubDate>Tue, 07 May 2013 13:18:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/hrs/anatomy/news/archive/2013/05/07/congratulations-victoria-dominguez-on-co-authoring-a-newly-release-paper.aspx</feedburner:origLink></item><item><title>Congratulations Athletic Training Class of 2013</title><link>http://feedproxy.google.com/~r/colmed/~3/qTTvxkPm2S0/congratulations-athletic-training-class-of-2013.aspx</link><description>&lt;div class="ExternalClassD2C8447731234C14B03AD4052007BDB9"&gt;&lt;p&gt;​May 5, 2013 - Congratulations to the 20 members of the Ohio State University Athletic Training Class of 2013.&lt;/p&gt;
&lt;p&gt;&lt;img alt="class of 2013 commencement.jpg" src="/hrs/at/news/Media/class%20of%202013%20commencement.jpg" class="ms-rteImage-1 ms-rtePosition-4" style="margin:5px;width:600px;height:450px" /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/qTTvxkPm2S0" height="1" width="1"/&gt;</description><pubDate>Mon, 06 May 2013 13:44:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/hrs/at/news/archive/2013/05/06/congratulations-athletic-training-class-of-2013.aspx</feedburner:origLink></item><item><title>Honoring the Professor of the Year: Dr. Kenneth Jones </title><link>http://feedproxy.google.com/~r/colmed/~3/91-pVDKxMII/honoring-the-professor-of-the-year-dr-kenneth-jones.aspx</link><description>&lt;div class="ExternalClass805D536714FF40F099D0F91B8C95B0E3"&gt;&lt;p&gt;Every year since 1931, the senior class of The Ohio State University’s College of Medicine recognizes one faculty member with the “Professor of the Year” award. The class of 2013 is proud to announce that this year’s recipient is Kenneth Jones, PhD. &lt;/p&gt;
&lt;p&gt;Currently an assistant professor emeritus in the Division of Anatomy, Dr. Jones began his career at Ohio State more than 35 years ago. He has taught medical and dental students and also played an integral role in developing the Biomedical Science major at OSU. He is an accomplished author and researcher and has received multiple other awards during his time at the College of Medicine. &lt;br /&gt;&lt;/p&gt;
&lt;p&gt;Jones once remarked that the best advice he had ever received was, “Wherever you go, settle in and work hard like you will be there for the rest of your life. This way, you will make the most out of your experiences.” &lt;/p&gt;
&lt;p&gt;Without question, he embraced and lived by those words during his time at OSU. &lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/91-pVDKxMII" height="1" width="1"/&gt;</description><pubDate>Mon, 06 May 2013 13:28:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/hrs/anatomy/news/archive/2013/05/06/honoring-the-professor-of-the-year-dr-kenneth-jones.aspx</feedburner:origLink></item><item><title>Certificate program in Comparative Effectiveness Research available</title><link>http://feedproxy.google.com/~r/colmed/~3/rrVGmTKBRoM/certificate-program-in-comparative-effectiveness-research-available.aspx</link><description>&lt;div class="ExternalClass922D0D86481B42718B99BD332ADF9C1B"&gt;&lt;p&gt;The College of Public Health is accepting enrollments now for a certificate program in comparative effectiveness research, a program prepared jointly by the COPH and the CCTS. The CER program, which utilizes online modules in addition to an in-person workshop held by Paul Hebert, PhD of the University of Washington, includes study design, methods, propensity scores, instrumental variables, linear regression, and translational science.&lt;/p&gt;
&lt;p&gt;See &lt;a href="http://cph.osu.edu/hopes/cer" target="_blank"&gt;more details&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;To enroll: &lt;a href="mailto:lgeist@cph.osu.edu" target="_blank"&gt;Laurel Geist&lt;/a&gt; (292-2383)&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/rrVGmTKBRoM" height="1" width="1"/&gt;</description><pubDate>Fri, 03 May 2013 20:33:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/research/news/archive/2013/05/03/certificate-program-in-comparative-effectiveness-research-available.aspx</feedburner:origLink></item><item><title>Athletic Training Faculty Member named a Fellow of the American College of Sports Medicine</title><link>http://feedproxy.google.com/~r/colmed/~3/5frSMQpTZCI/athletic-training-faculty-member-named-a-fellow-of-the-american-college-of-sports-medicine.aspx</link><description>&lt;div class="ExternalClassDCB22B7CB8ED4B8A84753D312A67DE2B"&gt;&lt;p&gt;​&lt;img class="ms-rteImage-1 ms-rtePosition-2" src="/hrs/at/news/Media/hunt_tamerah.jpg" alt="hunt_tamerah.jpg" style="margin:5px" /&gt;&lt;br /&gt;&lt;br /&gt;Athletic Training facutly member Dr. Tamerah Hunt has been named a 2013 Fellow of the &lt;a href="http://www.acsm.org/"&gt;American College of Sports Medicine&lt;/a&gt; (ACSM).  Dr. Hunt's area of expertise is concussion and Mild Traumatic Brain Injury and she is an  integral part of the OSU Sports Concussion Program, an 
interdisciplinary group developing novel evaluation, management and 
concussion research. As a researcher, she focuses on youth concussion 
assessment and has worked with high schools in several states examining 
high school recovery patterns, effort on concussion assessments, 
co-morbidities and possible educational intervention in at-risk 
populations.  She has recently completed a textbook on the concussed athete that should be available from the publisher later in 2013. &lt;/p&gt;
Being named a Fellow of the ACSM is a prestigious honor and the requirements for fellowship include an earned doctorate, membership and meeting attendance requirements,  an extensive record of either professional service or outstanding scholarship, and endorsement from two other Fellows.&lt;br /&gt;&lt;br /&gt;ACSM's Fellowship Program was created with the following purposes:&lt;br /&gt;&lt;br /&gt;

&lt;ul&gt;&lt;li&gt;To encourage high standards of professional responsibility
and service to the College. &lt;/li&gt;
&lt;li&gt;To promote and encourage a continuing program of
professional development.&lt;/li&gt;
&lt;li&gt;To recognize professional achievement and competence in the
related disciplines of sports medicine via education,published works,
professional practice and a demonstrated interest in and/or contribution to the
goals of sports medicine. Persons applying for Fellow status should have
demonstrated a high level of competence and ethical conduct with acceptable
knowledge of the principles and practices of sports medicine.&lt;/li&gt;
&lt;li&gt;To recognize the candidate who exhibits a deep and ongoing
interest and dedication to the goals and long-range activities of the American
College of Sports Medicine. Fellows shall have demonstrated active
participation in the College by attendance at the national and regional
meeting, presentations of papers and involvement in peer and public education
(i.e., workshops, symposia, lecture tours, etc.) The candidate should consider
the application for advancement to Fellow status to be a request to become more
active in the internal affairs of the College, including serving in a leadership
capacity. An applicant should not consider Fellow status for personal
gratification or enhancement.&lt;/li&gt;&lt;/ul&gt;

&lt;br /&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/5frSMQpTZCI" height="1" width="1"/&gt;</description><pubDate>Fri, 03 May 2013 17:32:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/hrs/at/news/archive/2013/05/03/athletic-training-faculty-member-named-a-fellow-of-the-american-college-of-sports-medicine.aspx</feedburner:origLink></item><item><title>TiGenix Reports Positive Phase IIa Study Results in Refractory Rheumatoid Arthritis with Allogeneic Stem Cell Product Cx611</title><link>http://feedproxy.google.com/~r/colmed/~3/d9OMQoCL9aw/tigenix-reports-positive-phase-iia-study-results-in-refractory-rheumatoid-arthritis-with-allogeneic-stem-cell-product-cx611-1.aspx</link><description>&lt;div class="ExternalClass75780C5E39A946DFBF8423C8AF035552"&gt;&lt;p&gt;&lt;span style="font-family:'arial', 'sans-serif';color:#004813;font-size:10pt"&gt;&lt;a href="http://www.tigenix.com/public/uploads/pdf/en/f5177d809eca202.40307502_TiGenix Cx611 Phase IIa results Final.pdf?elq=2bf69d731d8d41e7a6f2e3553c4a07bc"&gt;&lt;strong&gt;&lt;font color="#004813"&gt;TiGenix Reports Positive Phase IIa Study Results in Refractory Rheumatoid Arthritis with Allogeneic Stem Cell Product Cx611&lt;/font&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-family:'arial', 'sans-serif';font-size:10pt"&gt;&lt;br /&gt;TiGenix announced positive 6-month safety data of its Phase IIa study of Cx611 in rheumatoid arthritis, as well as a first indication of therapeutic activity on standard outcome measures and biologic markers of inflammation for at least three months after dosing. &lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/d9OMQoCL9aw" height="1" width="1"/&gt;</description><pubDate>Fri, 03 May 2013 16:08:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/03/tigenix-reports-positive-phase-iia-study-results-in-refractory-rheumatoid-arthritis-with-allogeneic-stem-cell-product-cx611-1.aspx</feedburner:origLink></item><item><title>American CryoStem Marks Major Global Expansion Milestone: Receives First International Shipment of Adipose Tissue for Processing and Cryo-Storage from Hong Kong</title><link>http://feedproxy.google.com/~r/colmed/~3/U4Omfka0osI/american-cryostem-marks-major-global-expansion-milestone-receives-first-international-shipment-of-adipose-tissue-for-processing-and-cryo-storage-from-hong-kong-1.aspx</link><description>&lt;div class="ExternalClassC4AD159D160D4584852D56D8C9AC2C07"&gt;&lt;p&gt;&lt;span style="font-family:'arial', 'sans-serif';color:#004813;font-size:10pt"&gt;&lt;a href="http://www.americancryostem.com/american-cryostem-marks-major-global-expansion-milestone-receives-first-international-shipment-of-adipose-tissue-for-processing-and-cryo-storage-from-hong-kong/?elq=2bf69d731d8d41e7a6f2e3553c4a07bc"&gt;&lt;strong&gt;&lt;font color="#004813"&gt;American CryoStem Marks Major Global Expansion Milestone: Receives First International Shipment of Adipose Tissue for Processing and Cryo-Storage from Hong Kong&lt;/font&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-family:'arial', 'sans-serif';font-size:10pt"&gt;&lt;br /&gt;American CryoStem Corporation announced receipt of its first commercial international shipment of adipose tissue for processing and long term cryo-storage&lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/U4Omfka0osI" height="1" width="1"/&gt;</description><pubDate>Fri, 03 May 2013 16:08:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/03/american-cryostem-marks-major-global-expansion-milestone-receives-first-international-shipment-of-adipose-tissue-for-processing-and-cryo-storage-from-hong-kong-1.aspx</feedburner:origLink></item><item><title>Mesoblast Reports Positive Interim Results in Phase II Trial of Proprietary Adult Stem Cells for Intervertebral Disc Repair</title><link>http://feedproxy.google.com/~r/colmed/~3/hNrw2hsrQIY/mesoblast-reports-positive-interim-results-in-phase-ii-trial-of-proprietary-adult-stem-cells-for-intervertebral-disc-repair.aspx</link><description>&lt;div class="ExternalClass7E84090E94DB42389DAB1FA2D1B18BA6"&gt;&lt;p&gt;&lt;span style="color:#004813;font-size:12pt"&gt;&lt;a href="http://www.mesoblast.com/newsroom/asx-announcements/?elq=2bf69d731d8d41e7a6f2e3553c4a07bc"&gt;&lt;span style="font-family:'arial', 'sans-serif';font-size:10pt"&gt;&lt;strong&gt;&lt;font color="#004813"&gt;Mesoblast Reports Positive Interim Results in Phase II Trial of Proprietary Adult Stem Cells for Intervertebral Disc Repair&lt;/font&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-family:'arial', 'sans-serif';font-size:10pt"&gt;Regenerative medicine company Mesoblast Limited announced that all 100 patients in its Phase II clinical trial of its proprietary mesenchymal precursor cells for intervertebral disc repair had completed six months of follow-up, the endpoint at which data will be evaluated for progression to Phase III. &lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/hNrw2hsrQIY" height="1" width="1"/&gt;</description><pubDate>Fri, 03 May 2013 16:08:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/03/mesoblast-reports-positive-interim-results-in-phase-ii-trial-of-proprietary-adult-stem-cells-for-intervertebral-disc-repair.aspx</feedburner:origLink></item><item><title>Mesenchymal Stem Cell Therapy in Skin: Why and What For?</title><link>http://feedproxy.google.com/~r/colmed/~3/l00LC4JIQw8/mesenchymal-stem-cell-therapy-in-skin-why-and-what-for.aspx</link><description>&lt;div class="ExternalClassB31B4E70C7354B698F3E75A99904E0BC"&gt;&lt;p&gt;&lt;span style="color:#004813;font-size:12pt"&gt;&lt;a href="http://onlinelibrary.wiley.com/doi/10.1111/exd.12141/abstract?elq=2bf69d731d8d41e7a6f2e3553c4a07bc"&gt;&lt;span style="font-family:'arial', 'sans-serif';font-size:10pt"&gt;&lt;strong&gt;&lt;font color="#004813"&gt;Mesenchymal Stem Cell Therapy in Skin: Why and What For?&lt;/font&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-family:'times new roman', 'serif';font-size:12pt"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-family:'arial', 'sans-serif';font-size:10pt"&gt;The authors contend that mesenchymal stem cells are not appropriate for cell replacement therapies in the context of wound healing. Indeed, engraftment of cells in the dermis is poor in the absence of irradiation and the observed effects seem mainly due to paracrine factors. &lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/l00LC4JIQw8" height="1" width="1"/&gt;</description><pubDate>Fri, 03 May 2013 16:08:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/03/mesenchymal-stem-cell-therapy-in-skin-why-and-what-for.aspx</feedburner:origLink></item><item><title>Self-Renewing Human Bone Marrow Mesenspheres Promote Hematopoietic Stem Cell Expansion</title><link>http://feedproxy.google.com/~r/colmed/~3/SjzZqfMz5eE/self-renewing-human-bone-marrow-mesenspheres-promote-hematopoietic-stem-cell-expansion.aspx</link><description>&lt;div class="ExternalClass5D8C502B1DEA478884CECC12577EAD26"&gt;&lt;p&gt;&lt;span style="font-family:'arial', 'sans-serif';color:#004813;font-size:10pt"&gt;&lt;a href="http://www.cell.com/cell-reports/abstract/S2211-1247(13)00165-4?elq=2bf69d731d8d41e7a6f2e3553c4a07bc"&gt;&lt;strong&gt;&lt;font color="#004813"&gt;Self-Renewing Human Bone Marrow Mesenspheres Promote Hematopoietic Stem Cell Expansion&lt;/font&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-family:'arial', 'sans-serif';font-size:10pt"&gt;&lt;br /&gt;Scientists describe a method of isolating and culturing human bone marrow stromal stem/progenitor cells as nonadherent mesenchymal spheres. Human mesenspheres were derived from CD45&lt;sup&gt;-&lt;/sup&gt; CD31&lt;sup&gt;-&lt;/sup&gt; CD71&lt;sup&gt;-&lt;/sup&gt; CD146&lt;sup&gt;+&lt;/sup&gt; CD105&lt;sup&gt;+&lt;/sup&gt; nestin&lt;sup&gt;+&lt;/sup&gt; cells but could also be simply grown from fetal and adult BM CD45&lt;sup&gt;-&lt;/sup&gt;-enriched cells. Human mesenspheres robustly differentiated into mesenchymal lineages. &lt;/span&gt;​&lt;/p&gt;&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/colmed/~4/SjzZqfMz5eE" height="1" width="1"/&gt;</description><pubDate>Fri, 03 May 2013 16:08:00 EST</pubDate><feedburner:origLink>http://medicine.osu.edu/regenerativemedicine/news/archive/2013/05/03/self-renewing-human-bone-marrow-mesenspheres-promote-hematopoietic-stem-cell-expansion.aspx</feedburner:origLink></item></channel></rss>
